Suppression of chloride voltage-gated channel 3 expression increases sensitivity of human glioma U251 cells to
Yihe Zhang1,2, Lei Zhou3, Juanjuan Zhang1
1Department of Pathophysiology, Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.
Abstract:
The mechanism of cisplatin resistance is complex. Previous studies have indicated that chloride voltage-gated channel 3 (CLCN3) is associated with drug resistance; however, the mechanisms are not fully understood. Therefore, the present study explored the involvement of CLCN3 in cisplatin resistance in human glioma U251 cells. The effects of combined cisplatin treatment and CLCN3 suppression on cultured U251 cells were investigated. The decreased viability of cisplatin-treated U251 cells indicated the cytotoxic effects of CLCN3 silencing. Expression of the apoptosis-related gene TP53 and caspase 3 activation were enhanced in cisplatin-treated U251 cells. Furthermore, the ratio of BCL2/BAX expression was decreased. Notably, CLCN3 suppression promoted cisplatin-induced cell damage in U251 cells. Thus, the combined use of cisplatin and CLCN3 antisense had additive effects in U251 cells. In addition, the present results indicated that CLCN3 suppression decreased lysosome stabilization in U251 cells treated with cisplatin. To conclude, the present results indicated that CLCN3 suppression can sensitize glioma cells to cisplatin through lysosomal dysfunction.
Insights
Suppression of chloride voltage-gated channel 3 (CLCN3) enhances cisplatin
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cisplatin resistance is a significant challenge in glioma treatment.
- Chloride voltage-gated channel 3 (CLCN3) has been implicated in drug resistance, but its precise role in cisplatin resistance remains unclear.
- Understanding the mechanisms of cisplatin resistance is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the role of CLCN3 in cisplatin resistance in human glioma U251 cells.
- To explore the effects of combined cisplatin treatment and CLCN3 suppression on glioma cell viability and apoptosis.
- To elucidate the underlying mechanisms, particularly lysosomal function, by which CLCN3 influences cisplatin sensitivity.
Main Methods:
- Human glioma U251 cells were treated with cisplatin alone or in combination with CLCN3 antisense.
- Cell viability was assessed to determine cytotoxic effects.
- Apoptosis-related gene expression (TP53, BCL2/BAX ratio) and caspase 3 activation were analyzed.
- Lysosome stabilization was evaluated in cisplatin-treated cells with and without CLCN3 suppression.
Main Results:
- CLCN3 suppression significantly decreased the viability of cisplatin-treated U251 cells.
- Combined treatment enhanced apoptosis, indicated by increased TP53 expression, caspase 3 activation, and a decreased BCL2/BAX ratio.
- CLCN3 suppression led to decreased lysosome stabilization in cisplatin-treated U251 cells, suggesting lysosomal dysfunction.
Conclusions:
- CLCN3 suppression sensitizes human glioma cells to cisplatin.
- The combination of cisplatin and CLCN3 antisense exhibits additive cytotoxic effects.
- Lysosomal dysfunction induced by CLCN3 suppression is a key mechanism mediating enhanced cisplatin sensitivity in glioma cells.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Mechanically-gated Ion Channels
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
G-Protein Gated Ion Channels
Sensory...
Ligand-Gated Ion Channel Receptor: Gating Mechanism


